Blockchain Registration Transaction Record

Greenland Mines Secures Australian Patent for Klotho Gene Therapy

Greenland Mines (GRML) secures Australian patent for Klotho gene therapy targeting ALS. Strengthens IP for KLTO-202 program. Learn more at Nasdaq-listed company's newsroom.

This patent is crucial as it protects a promising gene therapy for ALS and other neuromuscular diseases, potentially offering new hope to patients. For investors, it strengthens Greenland Mines' IP portfolio, enhancing its valuation in both biotech and mining sectors. The development also underscores the growing convergence of advanced therapies and resource companies, positioning Greenland Mines as a unique player in the market.